“Skip” Lenz, PharmD - Report on LDN Study (2016 Conference) (LDN, low dose naltrexone)

 

“Skip” Lenz, PharmD - Report on LDN Study (2016 Conference) (LDN, low dose naltrexone)

Download Dr. Lenz's LDN Study Presentation

“Report on the Longitudinal Study of the Effects, Side Effects & Interaction of Naltrexone in Low Dose”. 

The purpose of this presentation will evaluate the patient results of a three year study surveying the effectiveness of Low Dose Naltrexone (LDN).  The diagnoses involved include: Rheumatoid Arthritis, Fibromyalgia, Irritable Bowel Syndrome, ALS, Lou Gehrig’s Disease and Multiple Sclerosis. 

The studies for pain and other symptoms in each condition showed a significant improvement after initiating Low Dose Naltrexone (LDN). 

To watch past conference go to https://ldnresearchtrust.org/ldn-conferences